AMRA® Official (@AMRAMedical) header
AMRA® Official (@AMRAMedical) profile picture

A new global standard in body composition assessment offers multiple fat & muscle biomarkers with unrivaled precision & accuracy, from a rapid, whole-body MRI

Linköping, Sweden
Joined September 2015
How do we bridge the gap between AI innovation and clinical application? AI and Image Analysis Expert Iulian Emil Tampu, PhD are joining international leaders and policy makers to discuss the future of AI in healthcare and life sciences at Sweden–Singapore AI Outlook Days 2026
1
42
Beyond BMI: What can detailed body composition reveal about metabolic health in children? Join AMRA this Saturday at #ObesityWeek2026 from 7:30-8:30pm to learn more about recent research findings. Read more: eu1.hubs.ly/H0zR4sK0
1
56
We’re pleased to announce our partnership with #Voiant, bringing together #AMRAMedical’s validated quantitative MRI-based body composition biomarkers and Voiant’s advanced clinical trial imaging capabilities. Read the full announcement: eu1.hubs.ly/H0zQQ7p0
31
Our Insights in Brief article, explores findings from a secondary analysis of the Phase 3b STEP UP trial. AMRA® Researcher was used to characterize changes in adipose tissue, skeletal muscle volume and muscle fat infiltration during semaglutide treatment. eu1.hubs.ly/H0zPcj50
31
Live from AASLD’s The Liver Meeting 2026 in Denver! #AMRAMedical is contributing to four posters exploring how MRI-derived muscle measurements can provide deeper insights into muscle health in chronic liver disease and cirrhosis. Read more: eu1.hubs.ly/H0zG3kz0 #TLM26
76
Missed our recent presentation at #EASD2026? Watch AMRA’s Chief Scientific Officer Dr. Jennifer Linge present “COURAGE Body Composition: Muscle Composition Assessed by MRI”. ▶️ View Dr. Linge’s presentation here: easd.org/media-centre/#/sess… #GLP1 #MuscleComposition #AMRAMedical
1
53
We’re heading to #TLM26! AMRA is contributing to 4 studies exploring MRI-derived muscle health measures in liver disease, and their associations with long-term outcomes, post-transplant hospital burden, frailty & neurocognitive function. Connect with us: eu1.hubs.ly/H0zqz8P0
1
41
Tomorrow at the #ObesityDrugDevelopment Europe, #AMRA CSO Dr. Jennifer Linge will explore how MRI biomarkers can characterize muscle changes during weight loss, highlighting the value of looking beyond body weight alone during weight-management treatment.
🤖 Made with AI
38
A new analysis of Novo Nordisk’s STEP UP trial used AMRA® Researcher to look beyond weight loss, examining changes in muscle volume, muscle fat infiltration and adipose tissue during semaglutide-induced weight loss. Discover more: eu1.hubs.ly/H0zdpnS0
24
Strong discussions at #EASD2026 on the importance of looking beyond weight loss to better understand changes in muscle during #obesity treatment! Explore #AMRA’s quantitative MRI technology, enabling deeper insight into muscle and fat in metabolic trials: tinyurl.com/3xzj5zpf
40